Company
United StatesPublic company, NASDAQ: CYTKCytokinetics, Inc. (NASDAQ: CYTK), South San Francisco, CA – FDA Inspections
Inspection records and compliance data for Cytokinetics, Inc. in South San Francisco, California. 1 FDA inspection on record, last inspected March 03, 2025. Publicly traded as NASDAQ: CYTK.
Company Profile
This profile covers Cytokinetics, Inc. based in South San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 3, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 3, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1263928 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cytokinetics, Inc.
Stock ticker
CYTK
Exchange
NASDAQ
Share price
$55.58
Market cap
$7.7B
Price as of
November 6, 2026
FEI Number
3021637719
Address
350 Oyster Point Blvd, South San Francisco, California 94080, United States
Country
United States
ID: a982086a-70f7-40d9-8dc7-a32763fd553b